Leon Oliver Moulder's most recent trade in Zenas Biopharma Inc. was a trade of 57,000 Common Stock done at an average price of $18.0 . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.96 per share. | 02 Feb 2026 | 57,000 | 423,155 | - | 18.0 | 1,023,720 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.38 per share. | 07 Jan 2026 | 50,000 | 316,155 | - | 16.4 | 819,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.30 per share. | 07 Jan 2026 | 30,000 | 346,155 | - | 16.3 | 489,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.55 per share. | 07 Jan 2026 | 20,000 | 366,155 | - | 16.6 | 331,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 20.85 per share. | 07 Oct 2025 | 36,928 | 36,928 | - | 20.9 | 769,949 | Common Stock |
| Zai Lab Ltd (ADR) | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 72,602 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Leon Moulder Oliver | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 18 Feb 2025 | 25,000 | 266,155 | - | 6.7 | 166,750 | Common Stock |